Acute Myeloid Leukemia | Topics

Study Suggests AYAs Treated for AML Have High Risk of Developing Long-Term Complications
November 25, 2020

These results suggested that adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing long-term health complications.

Study Identifies Best Prophylaxis Option for Patients Undergoing HSCT and with AML or MDS
November 05, 2020

The study suggested that voriconazole (Vfend) may be the best prophylaxis option for patients undergoing HSCT, and posaconazole (Noxafil) may be the best prophylaxis option for patients with AML or MDS.

Eunice Wang, MD, on Treating AML During the COVID-19 Pandemic
November 04, 2020

The leukemia expert spoke about the importance of genetic testing for patients with acute myeloid leukemia and other important considerations for this patient population throughout the pandemic.